Kalpit Patel
Stock Analyst at Wolfe Research
(4.37)
# 1,207
Out of 4,423 analysts
217
Total ratings
36.9%
Success rate
15.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kalpit Patel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMAB Genmab | Maintained: Buy | $32 | $25.27 | +26.63% | 2 | Jun 14, 2026 | |
| TNGX Tango Therapeutics | Upgraded: Buy | $35 | $27.97 | +25.13% | 1 | Jun 8, 2026 | |
| ONC BeOne Medicines AG | Maintained: Buy | $340 | $270.15 | +25.86% | 3 | Jun 3, 2026 | |
| CGON CG Oncology | Maintained: Hold | n/a | $61.08 | - | 2 | May 26, 2026 | |
| CTMX CytomX Therapeutics | Initiated Coverage: Buy | $6 | $2.95 | +103.39% | 1 | May 19, 2026 | |
| MIRM Mirum Pharmaceuticals | Initiated Coverage: Buy | $145 | $107.13 | +35.35% | 1 | May 19, 2026 | |
| TYRA Tyra Biosciences | Initiated Coverage: Hold | n/a | $28.32 | - | 1 | May 19, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | $165 | $162.99 | +1.23% | 1 | May 6, 2026 | |
| CORT Corcept Therapeutics | Upgraded: Hold | n/a | $79.91 | - | 2 | Mar 26, 2026 | |
| KRYS Krystal Biotech | Initiated Coverage: Hold | n/a | $348.06 | - | 1 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $9.51 | - | 1 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $16 | $4.12 | +288.35% | 7 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $31.74 | +16.57% | 2 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $1.32 | n/a | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $38 → $60 | $90.43 | n/a | 13 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 | $16.63 | n/a | 17 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $85 → $28 | $8.26 | n/a | 3 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $14 | $4.00 | n/a | 12 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $6.23 | n/a | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $24 | $32.91 | n/a | 10 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 → $29 | $19.00 | n/a | 9 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.5 → $2 | $1.26 | n/a | 33 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $4.15 | n/a | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 → $15 | $4.22 | n/a | 5 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $2.27 | n/a | 3 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $7 | $2.00 | n/a | 14 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $14 | $0.955 | n/a | 5 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $12.14 | n/a | 6 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 9 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $82.49 | n/a | 9 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.43 | n/a | 6 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.21 | n/a | 10 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $6 | $0.0127 | n/a | 5 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $17.82 | n/a | 6 | Nov 26, 2021 |
Genmab
Jun 14, 2026
Maintained: Buy
Price Target: $32
Current: $25.27
Upside: +26.63%
Tango Therapeutics
Jun 8, 2026
Upgraded: Buy
Price Target: $35
Current: $27.97
Upside: +25.13%
BeOne Medicines AG
Jun 3, 2026
Maintained: Buy
Price Target: $340
Current: $270.15
Upside: +25.86%
CG Oncology
May 26, 2026
Maintained: Hold
Price Target: n/a
Current: $61.08
Upside: -
CytomX Therapeutics
May 19, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $2.95
Upside: +103.39%
Mirum Pharmaceuticals
May 19, 2026
Initiated Coverage: Buy
Price Target: $145
Current: $107.13
Upside: +35.35%
Tyra Biosciences
May 19, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $28.32
Upside: -
Revolution Medicines
May 6, 2026
Maintained: Buy
Price Target: $165
Current: $162.99
Upside: +1.23%
Corcept Therapeutics
Mar 26, 2026
Upgraded: Hold
Price Target: n/a
Current: $79.91
Upside: -
Krystal Biotech
Mar 26, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $348.06
Upside: -
Mar 26, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $9.51
Upside: -
Oct 10, 2025
Reiterated: Buy
Price Target: $13 → $16
Current: $4.12
Upside: +288.35%
Jul 21, 2025
Maintained: Buy
Price Target: $37
Current: $31.74
Upside: +16.57%
Jun 16, 2025
Maintained: Buy
Price Target: $5
Current: $1.32
Upside: n/a
Jun 3, 2025
Upgraded: Buy
Price Target: $38 → $60
Current: $90.43
Upside: n/a
May 21, 2025
Reiterated: Hold
Price Target: $19
Current: $16.63
Upside: n/a
May 7, 2025
Maintained: Buy
Price Target: $85 → $28
Current: $8.26
Upside: n/a
May 2, 2025
Maintained: Hold
Price Target: $17 → $14
Current: $4.00
Upside: n/a
Mar 27, 2025
Maintained: Buy
Price Target: $9
Current: $6.23
Upside: n/a
Mar 5, 2025
Maintained: Hold
Price Target: $20 → $24
Current: $32.91
Upside: n/a
Mar 3, 2025
Maintained: Buy
Price Target: $36 → $29
Current: $19.00
Upside: n/a
Feb 26, 2025
Downgraded: Hold
Price Target: $3.5 → $2
Current: $1.26
Upside: n/a
Jan 29, 2025
Initiated Coverage: Buy
Price Target: $10
Current: $4.15
Upside: n/a
Nov 18, 2024
Maintained: Hold
Price Target: $1 → $15
Current: $4.22
Upside: n/a
Sep 27, 2024
Reiterated: Buy
Price Target: $3
Current: $2.27
Upside: n/a
May 14, 2024
Maintained: Buy
Price Target: $10 → $7
Current: $2.00
Upside: n/a
Aug 14, 2023
Reiterated: Buy
Price Target: $12 → $14
Current: $0.955
Upside: n/a
Mar 21, 2023
Maintained: Buy
Price Target: $7
Current: $12.14
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $82.49
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $1.43
Upside: n/a
Aug 19, 2022
Rated: Hold
Price Target: n/a
Current: $1.21
Upside: n/a
Jun 7, 2022
Maintained: Buy
Price Target: $12 → $6
Current: $0.0127
Upside: n/a
Nov 26, 2021
Rated: Hold
Price Target: n/a
Current: $17.82
Upside: n/a